Drug Type Universal CAR-T |
Synonyms AUTO6 - Next Generation, AUTO 6 NG, AUTO6-NG |
Target |
Mechanism GD2 inhibitors(Disialoganglioside GD2 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Phase 1 | - | - | |
Small Cell Carcinoma | Preclinical | GB | 30 Jan 2022 | |
Osteosarcoma | Preclinical | GB | - | |
Skin Neoplasms | Preclinical | GB | - | |
Small Cell Lung Cancer | Preclinical | GB | - |